Catalogo dei prodotti della ricerca

DURANTE, COSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.590
EU - Europa 2.092
AS - Asia 1.046
SA - Sud America 66
AF - Africa 41
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.533
IT - Italia 1.189
SG - Singapore 349
IN - India 330
CN - Cina 303
SE - Svezia 301
FI - Finlandia 144
DE - Germania 84
UA - Ucraina 83
BG - Bulgaria 48
CA - Canada 44
BE - Belgio 38
IE - Irlanda 37
FR - Francia 36
AR - Argentina 34
GB - Regno Unito 34
NL - Olanda 30
TG - Togo 28
EC - Ecuador 25
RO - Romania 19
RU - Federazione Russa 19
MX - Messico 11
TR - Turchia 11
HK - Hong Kong 9
PH - Filippine 9
CH - Svizzera 8
IR - Iran 8
EG - Egitto 7
JP - Giappone 7
PL - Polonia 7
IQ - Iraq 5
AU - Australia 4
BR - Brasile 4
ES - Italia 4
KR - Corea 4
ZA - Sudafrica 4
AF - Afghanistan, Repubblica islamica di 3
AT - Austria 2
CL - Cile 2
DK - Danimarca 2
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BZ - Belize 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SC - Seychelles 1
VN - Vietnam 1
Totale 10.841
Salva come PNG Salva come JPEG
Città #
Fairfield 1.376
Ashburn 563
Woodbridge 559
Houston 492
Seattle 485
Rome 484
Chandler 474
Cambridge 448
Wilmington 422
Ann Arbor 331
Dearborn 305
Singapore 224
Princeton 187
Beijing 153
San Paolo di Civitate 139
Lawrence 121
Plano 116
Millbury 97
San Diego 95
Boston 71
New York 60
Milan 54
Des Moines 48
Helsinki 48
Sofia 48
Andover 46
Dublin 37
Fremont 36
Norwalk 32
Federal 31
Lomé 28
Phoenix 25
Boardman 24
Santa Clara 24
Toronto 24
Falls Church 23
Guayaquil 23
Brussels 22
Jacksonville 20
Hefei 19
Nanjing 17
Waanrode 16
Ottawa 14
Bologna 13
San Jose 13
Bühl 12
Cerignola 12
Kunming 12
Jinan 11
Nanchang 11
Redwood City 11
Lappeenranta 10
Istanbul 9
Bari 8
Bremen 8
Guangzhou 8
Shanghai 8
Torre del Greco 8
Carraia Nord 7
Grafing 7
Leawood 7
Mannheim 7
Paris 7
Tivoli 7
Verona 7
Catania 6
Foggia 6
Fort Worth 6
Hong Kong 6
Latina 6
Naples 6
Velletri 6
Washington 6
Fuzhou 5
Hangzhou 5
Hyderabad 5
London 5
Monterotondo 5
Padova 5
Palermo 5
Pune 5
Redmond 5
San Mateo 5
Shenyang 5
Turin 5
Augusta 4
Cagliari 4
Frankfurt am Main 4
Laurel 4
Los Angeles 4
Mexico City 4
Mumbai 4
Pisa 4
Sacramento 4
Tagbilaran 4
Torino 4
Warsaw 4
Amatrice 3
Amsterdam 3
Ancona 3
Totale 8.229
Salva come PNG Salva come JPEG
Nome #
Follicular thyroid cancer and Hurthle cell carcinoma: Challenges in diagnosis, treatment, and clinical management 132
Prospective evaluation of semiquantitative strain ratio and quantitative 2D ultrasound shear wave elastography (SWE) in association with TIRADS classification for thyroid nodule characterization 126
Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer 124
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. 118
Real-world performance of the American Thyroid Association Risk estimates in predicting 1-year differentiated thyroid cancer outcomes: a prospective multicenter study of 2000 patients 117
Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules 113
8th edition of AJCC/TNM staging system of thyroid cancer: what to expect (ITCO#2) 109
Identification of thyroid-associated serum microRNA profiles and their potential use in thyroid cancer follow-up 107
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: a case report 106
Follow-up of differentiated thyroid cancer – what should (and what should not) be done 103
Lack of association between obesity and aggressiveness of differentiated thyroid cancer 101
Reducing the number of unnecessary thyroid biopsies while improving diagnostic accuracy: towards the "right" TIRADS 100
Sonographic presentation of metastases to the thyroid gland: a case-series 98
Can ultrasound systems for risk stratification of thyroid nodules identify follicular carcinoma? 98
Is thyroid nodule location associated with malignancy risk? 97
Interobserver agreement of various thyroid imaging reporting and data systems 95
Pharmacokinetics, pharmacodynamics and clinical efficacy of dapagliflozin for the treatment of type 2 diabetes 95
Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound 94
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study 94
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 93
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization 93
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 92
The natural history of benign thyroid nodules 92
HABP2 Mutation and Nonmedullary Thyroid Cancer 92
Sonographically estimated risks of malignancy for thyroid nodules computed with five standard classification systems. Changes over time and their relation to malignancy 90
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 90
Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers 88
MicroRNA-based molecular classification of papillary thyroid carcinoma 88
Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer 87
Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments 87
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 87
Selective use of radioactive iodine therapy for papillary thyroid cancers with low or lower-intermediate recurrence risk 87
Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family 86
Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression 86
In silico drug repurposing in COVID-19. A network-based analysis 86
Temporal Changes in Thyroid Nodule Volume: Lack of Effect on Paranodular Thyroid Tissue Volume 84
Indeterminate thyroid nodules (TIR3A/TIR3B) according to the new Italian reporting system for thyroid cytology: a cytomorphological study 84
Screening for differentiated thyroid cancer in selected populations 83
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors 82
TSH receptor extracellular region mutations in thyroid functioning nodules: further evidence for the functional role of this region in the receptor activation 82
Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement? 81
Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients 81
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas 80
BRAF V600E -mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response 80
Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells 80
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas 80
Artificial intelligence for thyroid nodule characterization: where are we standing? 79
Taller-than-wide shape: a new definition improves the specificity of TIRADS systems 79
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 78
Thyroid nodule recurrence following lobo-isthmectomy: incidence, patient’s characteristics, and risk factors 78
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy 78
Clinical implications of BRAF mutation in thyroid carcinoma 77
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency 77
Epigenetics of thyroid cancer and novel therapeutic targets 75
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 75
Expression of YAP1 in aggressive thyroid cancer 75
Thyroid hormone therapy in differentiated thyroid cancer 75
A genetic based disease management in inherited cancer syndromes: the multiple endrocrine neoplasia model 74
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells 74
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates 74
Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies 73
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 73
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 73
Recent advances in managing differentiated thyroid cancer 73
Expression of PAX8 target genes in papillary thyroid carcinoma 72
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer 72
Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines 70
Is it worth suppressing TSH in low- and intermediate-risk papillary thyroid cancer patients before the first disease assessment? 70
Prognosis of patients with differentiated thyroid carcinomas having a preoperative cytological report of indeterminate at low or high risk. A multicenter study 70
Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy 70
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours 70
Contemporary debates in adult papillary thyroid cancer management 69
Thyroid ultrasonography reporting: consensus of Italian Thyroid Association (AIT), Italian Society of Endocrinology (SIE), Italian Society of Ultrasonography in Medicine and Biology (SIUMB) and Ultrasound Chapter of Italian Society of Medical Radiology (SIRM) 68
Different expression of TSH receptor and NIS genes in thyroid cancer: Role of epigenetics 68
ENDOCRINE TUMOURS: Imaging in the follow up of differentiated thyroid cancer: current evidence and future perspectives for a risk-adapted approach 67
A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma 67
null 67
Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC/PTC): An Italian multicenter study 67
RET mutation and increased angiogenesis in medullary thyroid carcinomas 67
[Cardiovascular disease and metabolic syndrome]. 66
Determination of calcitonin levels in C-cell disease: Clinical interest and potential pitfalls 66
Cancer care during COVID-19 era: the quality of life of patients with thyroid malignancies 66
PFAPA Syndrome in a Young Adult with a History of Tonsillectomy 65
Diagnostic performance of neck ultrasonography in the preoperative evaluation for extrathyroidal extension of suspicious thyroid nodules 65
Notch signaling is involved in expression of thyrocyte differentiation markers and is down-regulated in thyroid tumors 65
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies 64
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 64
Molecular defects in thyroid dysgenesis 64
Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules 64
Somatic amplifications and deletions in genome of papillary thyroid carcinomas 64
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 64
Sunitinib Exerts Only Limited Effects on the Proliferation and Differentiation of Anaplastic Thyroid Cancer Cells 63
Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma 63
Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations 63
Growth Factor Receptors Gene Expression and Akt Phosphorylation in Benign Human Thyroid Nodules are Unaffected by Chronic Thyrotropin Suppression 63
Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas 62
Targeting histone deacetylase in thyroid cancer 61
Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 61
Clinically silent thyroid cancers: drop those needles and scalpels! 61
Into the wardrobe of Narnia: beyond HIV infection a world of cardiovascular risk. 61
Totale 8.077
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 100
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.533
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.540 0 0 19 130 307 466 534 335 341 201 96 111
2020/20211.354 86 130 68 44 44 92 63 95 174 279 114 165
2021/20222.062 16 140 203 53 230 96 55 167 164 140 454 344
2022/20231.884 356 420 108 159 177 200 25 126 155 36 44 78
2023/20241.318 60 161 53 129 111 151 105 71 21 192 128 136
2024/2025289 92 101 96 0 0 0 0 0 0 0 0 0
Totale 11.539